USPTO serial 79047879
Serial No. 79047879
Reviewed by CopyMark Law Group
Reg. 3744800Status 706Registered
- Filing date
- Status date
- Registration date
- Feb 2, 2010
- Examiner
- MIDDLETON, BERNICE L
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with Serial No. 79047879?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Arthur DeBaugh
Arthur DeBaugh Allman Spry Leggett Crumpler & Horn, P.A.380 Knollwood Street, Suite 700Winston-Salem, NC 27103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, biological preparations, namely, antibodies, proteins, [ serum, ] enzymes and biotechnological preparations, namely, biotechnology formed enzymes or genes, nucleic acid probes, primers for polymerase chain reaction (PCR) amplification, preparations for scientific purposes; chemical biochemical, biological and biotechnological products, namely, suspension buffers, fluorescent dyes, staining and other reagents, cleaning solutions, [ sterilizing solutions, ] antibodies, biologically active proteins, peptides and nucleic acids for clinical or pre-clinical research use, reagents and assay kits comprised of reagents, chemicals and buffers for scientific use; chemical, biochemical, biological and biotechnical compounds for scientific use to fix cells, to permeabilize cells, to identify cells by fluorescent detection of by modification of optical properties, to modify cells and particle dielectrophoretic mobility, as suspension buffers for dielectrophoresis (DEP) manipulation, as culture media, and to separate cells; chemical, biochemical, biological and biotechnological products and preparations, namely, cell lines, antibodies, proteins, peptides, [ growth factors, ] buffers, substrates, [ DNA probes for scientific use, namely, for the identification of primary compounds with biological activity, namely, visibility, proliferation, apoptosis, lysis, phagocytosis, cell differentiation, transfection, gene-silencing, gene expression, protein production, translocation, secretion, other compounds uptake or release; ] chemical, biochemical, biological and biotechnological products, namely, suspension buffers, fluorescent dyes, staining and other reagents, [ cleaning solutions, sterilizing solutions, ] antibodies, biologically active proteins, peptides and nucleic acids, primers, reagents, and assay kits comprised of reagents, chemicals and buffers for laboratory analysis which is not for medical or veterinary use, products, namely, suspension buffers, fluorescent dyes, staining and other reagents, cleaning solutions, sterilizing solutions, antibodies, biologically active proteins, peptides and nucleic acids, primers, reagents and assay kits comprised of reagents, chemicals and buffers for diagnosis which is not for medical or veterinary use; chemical reagents not for medical or veterinary purposes; diagnostic reagents for clinical or medical laboratory use | ACTIVE | — |
| 009 | [ Computer and computer software for collection, organization, analysis, integration and communication of scientific records, namely, transmission, display, and archival of scientific records; ] equipment for carrying out biological clinical, physical and chemical-physical analysis, namely, cytometers and analyzers providing cell and particle analysis, detection, sorting or counting, sensor chips, cell and particle impedence, detectors, optical detector arrays, for scientific, laboratory and general research uses; [ electroporation instruments, cell fusion instruments, and microbead-functionalization instruments for the synthesis of chemical and biological substances; equipments and disposables, for scientific, laboratory, and general research uses, namely, plate reader, ] cell counter, [ spectrofluorometer, spectrometer, spectrum analyzer, interferometers, ] lasers, light emitting diodes, optical lenses, optical filters, optoelectronics, prisms, refractometers, hematology automated analyzer, flow cytometer, [ coagulometers, routine biochemistry analyzer, test tubes that can be used in chemical analyses, biological analyses or patterning for scientific or laboratory use; ] equipment for cell manipulation, namely, precision instruments for manipulation and positioning of microscopics; biochips and biosensors, namely, dielectrophoretic actuators, integrated optical and/or impedence sensor arrays, cell counting chips; electric and electronic memory units, namely, semi-conductor memory units for storing information such as images and analysis results data; magnetic and optical memory units, namely, hard-disks, DCD, CD, or storage information such as images and analysis results data; clinical, laboratory and analytical instruments, namely, [ cytometers, ] cell sorters, microscopes, cell separation devices; microfluidic devices, namely, programmable microelectronic electrode arrays for cell manipulation, micro-machined chips for cell separation and processing, for scientific, laboratory and general research uses; instrumental components and laboratory complementing instruments, namely, computer hardware and peripherals; laboratory disposable materials, namely, plastic or glass chips having multi-well arrays and silicon chips for scientific use, non-medical diagnostic research [, and therapy, namely, cell-therapy ] | ACTIVE | — |
| 010 | Equipment and instruments for blood testing, blood analysis, and genetic analysis in the field of reproductive health, oncology, cell sorting and manipulation devices for use in the medical, diagnostic, pharmaceutical [ or veterinary fields ]; equipment and instruments for stem cells isolation and processing, in regenerative medicine, namely, microfabricated cell-sorter chips and control equipment; apparatus for diagnosing human genetic disease, tumor, [ infection disease, by the application of biochip techniques, namely, microfabricated cell-sorter chips and control equipment; ] components and accessories for the aforesaid equipment and instruments, [ namely, filters for blood and blood components, ] biochips for cell sorting, biochips for sample preparation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SILICON BIOSYSTEMS S.p.A.
- Other trademarks owned by Menarini Silicon Biosystems S.p.A.
- Other trademarks owned by SILICON BIOSYSTEMS S.p.A.
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 010
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 31, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 31, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 15, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 15, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 15, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 3, 2021 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 13, 2020 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 13, 2020 | INPC | INVALIDATION PROCESSED | — |
| Oct 24, 2020 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 24, 2020 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 24, 2020 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jan 28, 2020 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Feb 4, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 2, 2019 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Nov 23, 2017 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 26, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 17, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 29, 2015 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 29, 2015 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 29, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 16, 2015 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Feb 5, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 25, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 25, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 2, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 2, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 17, 2009 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 17, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 13, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 5, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 8, 2009 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Sep 8, 2009 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Sep 4, 2009 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Sep 3, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 3, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 1, 2009 | PAPER RECEIVED | — | |
| Sep 1, 2009 | PAPER RECEIVED | — | |
| Jul 3, 2009 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 18, 2009 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 18, 2009 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 17, 2009 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 17, 2009 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 17, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 3, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 3, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2009 | PAPER RECEIVED | — | |
| Aug 29, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 25, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 14, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 14, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 25, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 25, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jul 24, 2008 | PAPER RECEIVED | — | |
| Feb 15, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 30, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 30, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 30, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 29, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 18, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Jan 17, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |